- Home
- PMF vs GNFT Comparison
PMF vs GNFT Comparison
Compare PMF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- GNFT
- Stock Information
- Founded
- PMF 2001
- GNFT 1999
- Country
- PMF United States
- GNFT France
- Employees
- PMF N/A
- GNFT 167
- Industry
- PMF Finance/Investors Services
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMF Finance
- GNFT Health Care
- Exchange
- PMF Nasdaq
- GNFT Nasdaq
- Market Cap
- PMF 248.9M
- GNFT 189.6M
- IPO Year
- PMF N/A
- GNFT 2019
- Fundamental
- Price
- PMF $9.00
- GNFT $3.80
- Analyst Decision
- PMF
- GNFT Strong Buy
- Analyst Count
- PMF 0
- GNFT 1
- Target Price
- PMF N/A
- GNFT $13.00
- AVG Volume (30 Days)
- PMF 61.3K
- GNFT 9.8K
- Earning Date
- PMF 01-01-0001
- GNFT 09-19-2024
- Dividend Yield
- PMF 5.36%
- GNFT N/A
- EPS Growth
- PMF N/A
- GNFT N/A
- EPS
- PMF N/A
- GNFT 0.47
- Revenue
- PMF N/A
- GNFT $86,225,222.00
- Revenue This Year
- PMF N/A
- GNFT $155.44
- Revenue Next Year
- PMF N/A
- GNFT N/A
- P/E Ratio
- PMF N/A
- GNFT $7.59
- Revenue Growth
- PMF N/A
- GNFT 175.45
- 52 Week Low
- PMF $7.69
- GNFT $3.31
- 52 Week High
- PMF $10.56
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- PMF 32.41
- GNFT 29.24
- Support Level
- PMF $8.88
- GNFT $3.63
- Resistance Level
- PMF $9.96
- GNFT $3.88
- Average True Range (ATR)
- PMF 0.19
- GNFT 0.10
- MACD
- PMF -0.05
- GNFT 0.02
- Stochastic Oscillator
- PMF 19.77
- GNFT 15.30
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.